Suggestions
Andrew Chang
Managing Director at United Airlines Ventures, Corporate Development
Andrew Chang is a well-accomplished individual with a varied background in both education and work experience. He attended the prestigious U.S Army Intelligence Center of Excellence, where he honed his skills in intelligence analysis. He continued his education by studying international affairs, business administration, international relations, and political science at The University of Georgia and The Fuqua School of Business.
Andrew has been a prolific investor and board member, having invested in companies such as Haas Alert, Babyation, Forcemetrics, Prepared, Delix Therapeutics, Spear Human Performance, Happy Health, Phosphorus, Qntfy, and Risk and Return. He was also a co-founder and Chief Operating Officer at Eastern Foundry, where he provided solutions to government contractors in the field of innovation.
Prior to his current roles, Andrew worked as a Cyber Threat Analyst at Novetta and an Intelligence Officer at the US Army. He was a lead researcher, intelligence analyst, and trainer at Endgame.
Andrew has a wealth of knowledge and skills that he has amassed throughout his illustrious career. His areas of expertise include intelligence analysis, cyber threat analysis, business administration, and innovation. He has a unique understanding of the government contracting process and has helped many organizations overcome barriers in this space. Andrew is a consummate professional who is passionate about his work and helping others succeed.
Highlights
🚨Coming soon to the #iOS18 and all Apple users this fall: Prepared📱
The assistive-AI platform, Prepared aims to increase accuracy of information for emergencies in real-time to make the correspondence between iPhone users and first responders seamless and safe- using live video, text, photos, and live location data.
Through Emergency SOS Live Video, 911 staff and dispatchers will be provided with a real-life account of the situation from the view of the iPhone user. With over 250 million calls that pour into 911 centers annually, accurate information is the key to efficiency.
Congratulations to the Prepared team and co-founders Michael, Dylan and Neal that made this happen!
Read more at:
Congrats to our partners at Delix Therapeutics on being awarded $825k by the United States Department of Defense to develop a nonhallucinogenic version of the famed counterculture drug LSD to treat hearing loss in service members.
